We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
XINT.ST

Price
0.37
Stock movement down
-0.02 (-4.17%)
Company name
Xintela AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
209.30M
Ent value
237.92M
Price/Sales
549.35
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-30.13%
1 year return
29.58%
3 year return
-40.51%
5 year return
-36.27%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

XINT.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales549.35
Price to Book-
EV to Sales624.46

FINANCIALS

Per share

Per share data
Current share count568.76M
EPS (TTM)-0.08
FCF per share (TTM)-0.11

Income statement

Income statement data
Revenue (TTM)381.00K
Gross profit (TTM)-1.52M
Operating income (TTM)-46.39M
Net income (TTM)-40.83M
EPS (TTM)-0.08
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)-397.90%
Operating margin (TTM)-12175.59%
Profit margin (TTM)-10716.80%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash445.00K
Net receivables6.72M
Total current assets9.81M
Goodwill0.00
Intangible assets56.00K
Property, plant and equipment0.00
Total assets10.93M
Accounts payable4.83M
Short/Current long term debt0.00
Total current liabilities29.06M
Total liabilities29.06M
Shareholder's equity-18.13M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-52.75M
Capital expenditures (TTM)104.00K
Free cash flow (TTM)-52.86M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-373.47%
Return on Invested Capital225.22%
Cash Return on Invested Capital291.56%

STOCK INFORMATION

Stock chart

Stock price data
Open0.37
Daily high0.39
Daily low0.36
Daily Volume79K
All-time high8.60
1y analyst estimate-
Beta1.76
EPS (TTM)-0.08
Dividend per share-
Ex-div date-
Next earnings date8 May 2025

Downside potential

Downside potential data
XINT.STS&P500
Current price drop from All-time high-95.72%-12.89%
Highest price drop-97.43%-56.47%
Date of highest drop24 May 20239 Mar 2009
Avg drop from high-65.17%-11.07%
Avg time to new high229 days12 days
Max time to new high1622 days1805 days
COMPANY DETAILS
XINT.ST (Xintela AB) company logo
Marketcap
209.30M
Marketcap category
Small-cap
Description
Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company's stem cell products include XSTEM that is in Phase I/IIa clinical development for the treatment of knee osteoarthritis, as well as in clinical study for the treatment of difficult-to-heal leg ulcers, acute respiratory distress syndrome, and other indications; and EQSTEM, which is in preclinical development for the treatment of joint disease in horses. It is also developing antibody-based cancer therapies, such as TARG9 and TARG10, which are in preclinical study for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. It has an agreement with Region Östergötland for GMP process development of cell therapy for burn patients. Xintela AB (publ) was incorporated in 2009 and is based in Lund, Sweden.
Employees
21
Website
https://www.xintela.se
Investor relations
-
SEC filings
XINT.ST SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved